Related Experiment Video
Updated: May 10, 2025

11:28
3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening
Published on: October 4, 2017
10.2K
3D printed microtissue cassettes enabling high throughput proton radiobiological assays
Chih-Tsung Yang1, I-Chun Cho2, Ching-Fang Yu3
1Future Industries Institute, University of South Australia, Adelaide, Australia.
Analytica Chimica Acta
|April 27, 2025
Summary
This study introduces a new 3D microtissue cassette for accurately measuring proton Relative Biological Effectiveness (RBE) in vitro. The method provides reliable RBE values, improving proton therapy planning and reducing toxicity.
Area of Science:
- Radiobiology
- Medical Physics
- Biotechnology
Background:
- Relative Biological Effectiveness (RBE) is crucial for translating photon therapy experience to proton beam therapy.
- Uncertainties in proton RBE within the spread-out Bragg peak (SOBP) can lead to suboptimal treatment and increased toxicity.
- Accurate RBE determination is essential for precise proton therapy planning.
Purpose of the Study:
- To develop and validate a reliable analytical method for determining proton RBE in vitro.
- To assess proton RBE along the SOBP and distal fall-off regions.
- To enable high-throughput assessment of radiobiological effects using a 3D microtissue cassette.
Main Methods:
- Development of a 3D microtissue cassette for high-throughput biological assays.
- In vitro irradiation of microtissues using a single proton beam.
- Assessment of cell survival using clonogenic assays.
- Quantification of DNA double-strand breaks using the γ-H2AX assay.
Main Results:
- Proton RBE values determined by clonogenic assay were 1.3, 1.5, and 1.6 at 90%, 50%, and 10% cell survival, respectively.
- RBE values from the γ-H2AX assay were consistent with clonogenic assay results (1.58 at 10% cell survival).
- The 3D cassette demonstrated high spatial resolution, detecting subtle changes in DNA damage response.
Conclusions:
- The 3D printed cassette reliably addresses critical radiobiological questions regarding proton RBE.
- This high-throughput methodology reduces time and resource burdens for clinical facilities.
- The approach is adaptable for investigating other charged particle radiation therapy modalities.

